Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FEMMV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,374
Award facts
- Contract value 100% obligated
- $15,373.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $15,373.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This firm fixed-price delivery order, issued on November 12, 2025, with an ultimate completion date of November 14, 2025, was awarded without set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products and medical consumables to support Department of Defense healthcare operations, including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, specialty pharmaceuticals, and oncology treatments.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion government-wide acquisition strategy. The parent IDC, designated SPE2DR and awarded on November 13, 2025, carries a ceiling value of $499.999 billion and extends through December 31, 2036, comprising a 30-month base period with three 30-month option periods. As an authorized prime vendor under this strategic pharmaceutical supply initiative, DMS Pharmaceutical Group is positioned to deliver essential medical supplies to military healthcare facilities worldwide, supporting the Department of Defense's recurring pharmaceutical and medical consumables requirements.
Quick answers
Who was awarded contract SPE2DU26FEMMV?
SPE2DU26FEMMV was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DU26FEMMV worth?
The government has obligated $15,374 on SPE2DU26FEMMV.
Is contract SPE2DU26FEMMV an order under another contract?
Yes. SPE2DU26FEMMV is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMMV competed?
The extent of competition for SPE2DU26FEMMV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award